Response to immune complex vaccine in chronic hepatitis B patients is associated with lower baseline level of serum IgG galactosylation

The composition of glycan in immunoglobulin G (IgG) has shown to affect various diseases and can be regulated by drugs and preventive vaccination. A hepatitis B surface antigen (HBsAg)-hepatitis B immunoglobulin (HBIG) immune complex (YIC) therapeutic vaccine for chronic hepatitis B (CHB) patients h...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jing, Gong, Guo-Zhong, Lei, Jian-Hua, Qin, Wen-Jun, Qin, Rui-Huan, Wang, Xuan-Yi, Gu, Jian-Xin, Ren, Shi-Fang, Wen, Yu-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617443/
https://www.ncbi.nlm.nih.gov/pubmed/31261570
http://dx.doi.org/10.1097/MD.0000000000016208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617443/
https://www.ncbi.nlm.nih.gov/pubmed/31261570
http://dx.doi.org/10.1097/MD.0000000000016208

Ejemplares similares